BELVIQ® (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960.
Published December 24, 2014 · Recall initiated: December 5, 2014
Summary
FDA records drug Class III recall D-0302-2015, published December 24, 2014 and initiated December 5, 2014. Recalling firm: Eisai Inc; Status: Terminated; Reported quantity: 121,680 bottles; Lot: Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15. Class III means the product is not likely to cause adverse health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Eisai Inc
- Distributor
- Nationwide.
- Lot
- Lot #13297008, Exp. 11/15;13307008, Exp. 11/15;13367008, Exp.12/15.
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAClinimix E 4.25/10 sulfite-free (4.25% Amino Acid with Electrolytes in 10% Dextrose with Calcium) Injections,December 24, 2014
- FDAMeropenem I.V. 1 g is supplied in 30 mL injection vials, RX only. Manufactured by Hospira Healthcare IndiaDecember 24, 2014
- FDAMercaptopurine Tablets, USP, 50 mg, 30 Tablets (3 x 10) unit dose blisters per carton, Rx only, ManufacturedDecember 24, 2014
- FDAWockhardt Metoprolol Succinate, Extended-Release Tablets USP, 50 mg, a)100-count HDPE bottle (NDCDecember 24, 2014
- FDABenzonatate Capsules, USP, 200 mg, 100-count bottles, Rx only, Manufactured by: Cadila Healthcare Ltd,December 24, 2014
- FDASOLGAR ENHANCED SERIES ABC DOPHILUS POWDER FOR INFANTS AND CHILDREN, NET WT. 1.75 oz (50 g), UPC 0 33984 00010December 24, 2014
Questions about this recall
Was BELVIQ® (Lorcaserin HCl) Tablets, 10 mg, 60-count bottle, Rx only, Manufactured by: Arena Pharmaceuticals, GmbH, Zofingen, Switzerland, Distributed by: Elsai Inc., Woodcliff, NJ 07677 NDC 62856-52960. recalled?
Yes. FDA published recall D-0302-2015 on December 24, 2014. Reported hazard: Labeling:Missing Label: Bottles may not have a product label, or have a label with missing or illegible lot number and/or expiry date.
What should I do if I have this product?
Voluntary: Firm initiated · Letter